163 related articles for article (PubMed ID: 31496961)
1. Responder Analysis of a Multicomponent Non-Pharmacological Intervention (MAKS) for People With Cognitive Impairment in the German Day-Care Study (DeTaMAKS).
Luttenberger K; Graessel E; Behrndt EM; Özbe D; Donath C; Scheel J
Front Psychiatry; 2019; 10():587. PubMed ID: 31496961
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of a non-pharmacological treatment vs. "care as usual" in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial.
Steinbeisser K; Schwarzkopf L; Graessel E; Seidl H
Eur J Health Econ; 2020 Aug; 21(6):825-844. PubMed ID: 32219623
[TBL] [Abstract][Full Text] [Related]
3. Non-Pharmacological Treatment in People With Cognitive Impairment.
Straubmeier M; Behrndt EM; Seidl H; Özbe D; Luttenberger K; Graessel E
Dtsch Arztebl Int; 2017 Dec; 114(48):815-821. PubMed ID: 29249224
[TBL] [Abstract][Full Text] [Related]
4. The Erlangen test of activities of daily living in persons with mild dementia or mild cognitive impairment (ETAM) - an extended validation.
Book S; Luttenberger K; Stemmler M; Meyer S; Graessel E
BMC Psychiatry; 2018 Sep; 18(1):308. PubMed ID: 30249231
[TBL] [Abstract][Full Text] [Related]
5. Non-pharmacological, psychosocial MAKS-s intervention for people with severe dementia in nursing homes: results of a cluster-randomised trial.
Kratzer A; Diehl K; Gefeller O; Meyer S; Graessel E
BMC Geriatr; 2022 Dec; 22(1):1001. PubMed ID: 36577973
[TBL] [Abstract][Full Text] [Related]
6. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.
Hsu TJ; Tsai HT; Hwang AC; Chen LY; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():28-35. PubMed ID: 28436192
[TBL] [Abstract][Full Text] [Related]
7. [Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility].
Hashidate H; Harada K; Asakawa Y; Yamagami T; Nihei K; Kaneya S; Yoshii C
Nihon Koshu Eisei Zasshi; 2012 Aug; 59(8):532-43. PubMed ID: 23066632
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM).
Luttenberger K; Reppermund S; Schmiedeberg-Sohn A; Book S; Graessel E
BMC Geriatr; 2016 May; 16():111. PubMed ID: 27229937
[TBL] [Abstract][Full Text] [Related]
9. [Implementation and Effect of the Multimodal Psychosocial MAKS Intervention in Day Care Centers for People with Cognitive Impairment: Follow-up Results After the End of the RCT].
Gräßel E; Donath C; Pendergrass A; Luttenberger K
Gesundheitswesen; 2022 Dec; 84(12):1154-1157. PubMed ID: 34560797
[TBL] [Abstract][Full Text] [Related]
10. Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomizied, controlled trial.
Graessel E; Stemmer R; Eichenseer B; Pickel S; Donath C; Kornhuber J; Luttenberger K
BMC Med; 2011 Dec; 9():129. PubMed ID: 22133165
[TBL] [Abstract][Full Text] [Related]
11. The German day-care study: multicomponent non-drug therapy for people with cognitive impairment in day-care centres supplemented with caregiver counselling (DeTaMAKS) - study protocol of a cluster-randomised controlled trial.
Behrndt EM; Straubmeier M; Seidl H; Book S; Graessel E; Luttenberger K
BMC Health Serv Res; 2017 Jul; 17(1):492. PubMed ID: 28716141
[TBL] [Abstract][Full Text] [Related]
12. Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial.
Luttenberger K; Hofner B; Graessel E
BMC Neurol; 2012 Dec; 12():151. PubMed ID: 23217188
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey RJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
[TBL] [Abstract][Full Text] [Related]
15. Memantine for dementia.
McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
[TBL] [Abstract][Full Text] [Related]
16. The DemWG study: reducing the risk of hospitalisation through a complex intervention for people with dementia and mild cognitive impairment (MCI) in German shared-housing arrangements: study protocol of a prospective, mixed-methods, multicentre, cluster-randomised controlled trial.
Kratzer A; Scheel J; Wolf-Ostermann K; Schmidt A; Ratz K; Donath C; Graessel E
BMJ Open; 2020 Dec; 10(12):e041891. PubMed ID: 33268431
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of sleep disorders and behavioral and psychological symptoms of dementia in late-onset Alzheimer disease: A study in Eastern China.
Zhou G; Liu S; Yu X; Zhao X; Ma L; Shan P
Medicine (Baltimore); 2019 Dec; 98(50):e18405. PubMed ID: 31852160
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
